Related Experiment Video
Updated: Oct 4, 2025

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
Published on: July 28, 2020
Local tranexamic acid reduces surgical blood loss
1Thomas Edison State University, Trenton, New Jersey; Department of Surgery, Rutgers Robert Wood Johnson Medical School,New Brunswick, New Jersey.
Tranexamic acid (TXA) effectively reduces blood loss in surgery. Recent studies confirm its efficacy when applied topically or systemically, especially in orthopedic and spinal procedures.
Area of Science:
- Orthopedics
- Anesthesiology
- Pharmacology
Background:
- Tranexamic acid (TXA), a synthetic lysine analog, inhibits plasminogen, reducing blood loss.
- Previous research highlighted TXA's effectiveness in orthopedic and cesarean surgeries.
- The optimal delivery method (local vs. systemic) for TXA remains under investigation.
Purpose of the Study:
- To review recent studies on TXA's efficacy in surgical blood loss reduction.
- To explore the impact of combined local and systemic TXA delivery.
- To assess topical TXA's effectiveness in hip arthroplasty.
Main Methods:
- Review of two recent studies on TXA in spinal surgery and hip arthroplasty.
- Analysis of randomized controlled trials (RCTs) on TXA for surgical blood loss.
- Comparison of local, systemic, and combined TXA administration routes.
Main Results:
- Combined systemic and topical TXA improved outcomes in hip arthroplasty.
- A single topical dose of TXA was effective in hip arthroplasty.
- Systemic TXA alone did not improve outcomes in ambulatory foot and ankle surgery.
Conclusions:
- TXA demonstrates efficacy in reducing surgical blood loss across various procedures.
- Combined local and systemic administration may offer superior benefits.
- Further research is needed to establish optimal TXA delivery protocols.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Venous Thrombosis III: Interprofessional Care

